Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Information Technology · ·
$378.47
▲ $10.77 (+2.9%)
Market data updated: 09/17 09:32 AM
Fundamentals updated: 09/16/2026
News analyzed: 09/17/2026
Market Cap
$72.53B
Day Range
$367.45 - $379.94
52-Week Range
$362.55 - $539.48
Beta
—
Next Earnings
08.12.2026
SNPS is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
-12.3% (1Y)
Strengths: 8/31 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Leverage risk
Debt/equity: 0.48
Risk
Biggest negative driver
DCF Fair Value
Estimated fair value: $105.90 vs. price $378.47 (-72.0%)
Fair Value
What to watch next
When today echoes the past.
74/100
Similarity
15
Historical Matches
88/100
Analog Quality
+6.6%
Median 40D Outcome
49/100
Pattern Consistency
🟢 Bullish
53%
+5.2% … +13.1%
🟡 Base
0%
— … —
🔴 Bearish
47%
-7.7% … -2.6%
Typical timeframe (based on real historical rates clearing a 60% bar): 40 trading days.
📌 Bottom line: Out of 15 similar historical cases for this stock, 53% (95% CI 30%–75%) saw the stock rise within 20 trading days, with a median gain of +4.1%.
Echo #1 — Oversold Reversal
1 occurrence(s) · 100% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 40% (20%–64%) | +0.3% | -2.7% … +3.2% | +0.7% |
| 10D | 33% (15%–58%) | -0.1% | -2.4% … +2.6% | +1.3% |
| 20D | 53% (30%–75%) | +4.1% | -4.2% … +7.4% | +2.3% |
| 40D | 73% (48%–89%) | +6.6% | -0.2% … +20.3% | +4.1% |
| 60D | 80% (55%–93%) | +15.7% | +6.3% … +17.2% | +6.0% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2026-06-10 | 74/100 | Consolidation | -3.3% | -14.5% |
| 2022-05-09 | 72/100 | Downtrend | +25.6% | +41.9% |
| 2025-02-27 | 71/100 | Downtrend | -1.9% | +9.7% |
| 2022-04-22 | 69/100 | Downtrend | +7.6% | +16.0% |
| 2024-12-18 | 68/100 | Downtrend | +7.1% | -8.9% |
| 2026-04-02 | 68/100 | Downtrend | +23.5% | +12.7% |
| 2024-09-05 | 67/100 | Downtrend | +4.1% | +17.3% |
| 2022-01-19 | 67/100 | Consolidation | -1.7% | -5.6% |
| 2021-03-03 | 66/100 | Consolidation | +4.6% | +7.5% |
| 2020-03-11 | 66/100 | Downtrend | +5.4% | +38.9% |
| 2026-02-27 | 66/100 | Downtrend | -8.1% | +29.1% |
| 2025-10-16 | 65/100 | Downtrend | -10.5% | +16.3% |
| 2026-02-02 | 64/100 | Downtrend | -7.3% | +5.1% |
| 2024-01-03 | 64/100 | Consolidation | +9.7% | +17.2% |
| 2025-03-13 | 63/100 | Downtrend | -5.1% | +15.7% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLK (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
45
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
45
Quality
47
Value
33
Momentum
13
Risk
46
Sentiment
100
Fundamental
66
Institutional
0
Stocks with a similar DNA right now
SCANNING SNPS...
Recent media coverage of Synopsys has focused on its stock performance amid broader semiconductor sector shifts. Notably, Morgan Stanley upgraded Synopsys to **Overweight**, highlighting its strong valuation relative to European chip peers and signaling confidence in its resilience as the memory cycle nears a late-stage turn. While broader chip stocks face selective scrutiny, Synopsys was singled out for its differentiated position, though overall market volatility and rate-hike concerns remain in focus.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Synopsys. News trend score: 100. Reason: 10 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
37
🎯 Conviction (vs. Emotion)
37
Psychology
72
Fundamentals
66
Technical
13
Valuation
33
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
The price rise has far outpaced the actual improvement in fundamental data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
-20%
Market Narrative
65
Fundamental Reality
37
Narrative Gap
+28
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The dominant **herding** behavior (score 49) reflects SNPS moving in lockstep with peers (ACN, ADBE, AMD) despite minimal divergence, suggesting passive alignment rather than aggressive conviction. The **narrative-reality gap** (39) hints at extreme optimism (sentiment 100/100) clashing with technical weakness (RSI 44, -0.5% ROC), while **overconfidence** (45) and **euphoria** (35) stem from detached valuation (+270% DCF premium). The key tension lies between **loss aversion** (35)—holding despite recent declines—and **herding**, which may delay corrective action until peers act. The open question: *Will herding sustain despite mounting technical contradictions?*
Updated: 09/09/2026, 09:11 AM
What could change this?
👥 What the crowd believes
"Morgan Stanley has upgraded Synopsys to Overweight"
"How to Play SNPS Stock as Layoffs Hit Synopsys"
📈 11D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 97/100
🔴 Weakest match
Jesse Livermore — 10/100
🗣️ Why do they disagree?
The stark divide in verdicts for SNPS reflects deep methodological differences in how these investors assess stocks. Samuel Armstrong Nelson’s high score suggests he’d see the stock as near oversold and cyclically favorable, while the majority—especially Graham, Livermore, and Veblen—flag it as risky or mispriced, with Livermore even calling it a negative trend. Fisher, Lynch, and the Enterprising Investor variant reject it outright for lacking growth or value signals, whereas Marks (both variants) and Housel acknowledge its merits but temper enthusiasm with caution about inflated expectations. Meanwhile, Mackay and Schwager’s mid-range scores hint at cautious optimism, balancing crowd sentiment or neutral cycle positioning against a lack of decisive edge.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 97
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 75
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 65
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 57
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 52
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 51
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 42
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 42
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 42
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 42
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 40
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 34
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 26
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 25
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 12
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 10
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 10 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A trading range after a decline, but still without clear (volume-based) confirmation of an accumulation phase.
Low confidence
$362.55
Range Bottom
$464.98
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
77.0%
Operating Margin
13.0%
Net Margin
18.9%
EBITDA Margin
22.3%
ROE
4.7%
ROA
2.8%
ROIC
—
EPS
$8.13
Cash
$2.89B
Total Debt
$13.48B
Current Ratio
1.62
Debt/Equity
0.48
How is Fair Value calculated? →
Current Price
$378.47
Estimated Fair Value (DCF)
$105.90
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-72.0%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
15.2%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 15.2% | $1.55B | $1.43B |
| 2 | 12.0% | $1.74B | $1.47B |
| 3 | 8.8% | $1.89B | $1.46B |
| 4 | 5.7% | $2.00B | $1.42B |
| 5 | 2.5% | $2.05B | $1.33B |
Base FCF (last actual year)
$1.35B
Terminal Value
$32.36B
Present Value of Terminal Value
$21.03B
Enterprise Value
$28.14B
Net Debt
$10.60B
Equity Value
$17.54B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$171.00
Tangible Book Value per Share (Tangible NAV)
-$67.92
Sentiment based on basic keywords (not AI) — 10 positive, 10 neutral, 0 negative out of the last 20 articles.
Yahoo · 17.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Trefis · 14.9.2026
Yahoo · 14.9.2026
InvestorsHub · 14.9.2026
Yahoo · 14.9.2026
24/7 Wall St. · 14.9.2026
Yahoo · 14.9.2026
Zacks · 14.9.2026
Yahoo · 14.9.2026
Business Wire · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 12.9.2026
24/7 Wall St. · 12.9.2026
Benzinga · 11.9.2026
Trefis · 11.9.2026
Synopsys (SNPS) currently has a StockIQ AI score of 45/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
SNPS currently scores 45/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, SNPS's estimated fair value is $105.90, which is 72.0% below the current price of $378.47. This is one valuation model among several signals in the fair-value category, not a price target.
SNPS's technical score is 13/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Debt/equity: 0.48; Current ratio: 1.62; Gross margin: 77.0% — strong.
Based on the real signals StockIQ computed: Estimated fair value: $105.90 vs. price $378.47 (-72.0%); Operating margin is eroding over time; ATR: 4.3% of price.
StockIQ has no recorded dividend payment history for SNPS.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 4 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| DE GEUS AART | Open Market Sale | 1.9.2026 | 24,641 | -24,641 | $419.44 |
| DE GEUS AART | Exercise of Derivative Securities | 1.9.2026 | 24,641 | +24,641 | $135.88 |
| DE GEUS AART | Exercise of Derivative Securities | 1.9.2026 | 24,641 | -24,641 | — |
| LEE JANET | Exercise of Derivative Securities | 1.9.2026 | 699 | +699 | — |
| LEE JANET | Exercise of Derivative Securities | 1.9.2026 | 699 | -699 | — |
| LEE JANET | Tax Withholding in Shares | 1.9.2026 | 304 | -304 | $414.82 |
| Ghazi Sassine | Other Transaction | 31.8.2026 | 27 | +27 | $360.96 |
| DE GEUS AART | Exercise of Derivative Securities | 31.8.2026 | 25,000 | -25,000 | — |
| Kankanwadi Sudhindra | Other Transaction | 31.8.2026 | 27 | +27 | $360.96 |
| DE GEUS AART | Open Market Sale | 31.8.2026 | 25,000 | -25,000 | $441.76 |
| DE GEUS AART | Other Transaction | 31.8.2026 | 22 | +22 | $360.96 |
| Ellow Michael | Other Transaction | 31.8.2026 | 27 | +27 | $360.96 |
| DE GEUS AART | Exercise of Derivative Securities | 31.8.2026 | 25,000 | +25,000 | $135.88 |
| DE GEUS AART | Exercise of Derivative Securities | 28.8.2026 | 145,421 | +25,000 | $135.88 |
| DE GEUS AART | Exercise of Derivative Securities | 28.8.2026 | 49,641 | -25,000 | — |
| DE GEUS AART | Open Market Sale | 28.8.2026 | 120,421 | -25,000 | $445.55 |
| DE GEUS AART | Exercise of Derivative Securities | 28.8.2026 | 25,000 | -25,000 | — |
| DE GEUS AART | Open Market Sale | 28.8.2026 | 25,000 | -25,000 | $445.55 |
| DE GEUS AART | Exercise of Derivative Securities | 28.8.2026 | 25,000 | +25,000 | $135.88 |
| LEE JANET | Exercise of Derivative Securities | 16.8.2026 | 729 | -729 | — |
| LEE JANET | Tax Withholding in Shares | 16.8.2026 | 318 | -318 | $421.50 |
| LEE JANET | Exercise of Derivative Securities | 16.8.2026 | 729 | +729 | — |
| Kankanwadi Sudhindra | Exercise of Derivative Securities | 15.6.2026 | 720 | -720 | — |
| DE GEUS AART | Tax Withholding in Shares | 15.6.2026 | 156 | -156 | $454.38 |
| Ellow Michael | Tax Withholding in Shares | 15.6.2026 | 2,007 | -2,007 | $454.38 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
5,214,211 shares short as of 2026-08-31 · vs. 5,242,368 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
44.6% of trading volume this week was short selling, vs. 46.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology